| Criterion Text | Inclusion/Exclusion | Disease | Biomarker | Prior Therapy | Criterion Rule |
| --- | --- | --- | --- | --- | --- |
| Known active central nervous system (CNS) metastases and/or carcinomatous meningitis | Exclusion | Metastatic brain disease | - | - | !(CNSMetastases || CarcinomatousMeningitis) |

Note:

* Criterion Text: "Known active central nervous system (CNS) metastases and/or carcinomatous meningitis"
* Inclusion/Exclusion: "Exclusion" indicates that this criterion is an exclusion criterion.
* Disease: "Metastatic brain disease" is the disease associated with this criterion.
* Biomarker: There is no biomarker associated with this criterion.
* Prior Therapy: There is no prior therapy associated with this criterion.
* Criterion Rule: The criterion rule is "!(CNSMetastases || CarcinomatousMeningitis)", which translates to "not (CNS metastases or carcinomatous meningitis)". This means that patients with known active CNS metastases and/or carcinomatous meningitis are excluded from the clinical trial.